Why is $APRE moving today? · SEC 8-K archive

$APRE SEC Filing Alert & Real-Time AI Stock Impact Analysis

T0 SEO archive for $APRE: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).

← All archive signals

FAQ: $APRE filing catalyst

Why did $APRE trigger an AI stock catalyst alert?

$APRE triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: -1.5/10). Headline: Aprea Therapeutics Reports Q3 2026 Operating Loss of $5.2M, Cash Runway Into Q1 2028. Key points: - Operating loss expanded to $5.2 million for Q3 2026 from $3.1 million in Q3 2025. - Cash and equivalents stood at $37.8 million as of September 30, 2026, funding runway into Q1 2028. - Phase 1 interim clinical data for APR-1051 scheduled for presentation at ENA Symposium on November 20, 2026.

How did $APRE stock react after the SEC filing?

After the SEC 8-K for $APRE, observed market reaction: T0 price $0.52. Past moves do not guarantee future results.

Where can I get real-time $APRE SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $APRE via Telegram and the VIP Web Terminal from €10/month.

$APRE

$APRE – Aprea Therapeutics Reports Q3 2026 Operating Loss of $5.2M, Cash Runway Into Q1 2028

Aprea Therapeutics, Inc.

2026-11-04 00:00:00 UTC · SEC 8-K · All $APRE

Unlocked archive · Analyzed in <2s at T0

Bearish AI Sentiment (-1.5 / 10)

Operating loss expanded to $5.2 million for Q3 2026 from $3.1 million in Q3 2025.
Cash and equivalents stood at $37.8 million as of September 30, 2026, funding runway into Q1 2028.
Phase 1 interim clinical data for APR-1051 scheduled for presentation at ENA Symposium on November 20, 2026.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →